Literature DB >> 16302800

Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase.

Alex N Bullock1, Judit E Debreczeni, Oleg Y Fedorov, Adam Nelson, Brian D Marsden, Stefan Knapp.   

Abstract

The kinase PIM-1 plays a pivotal role in cytokine signaling and is implicated in the development of a number of tumors. The three-dimensional structure of PIM-1 is characterized by an unique hinge region which lacks a second hydrogen bond donor and makes it particularly important to determine how inhibitors bind to this kinase. We determined the structures of PIM-1 in complex with bisindolylmaleimide (BIM-1) and established the structure-activity relationship (SAR) for this inhibitor class. In addition, we screened a kinase targeted library and identified a number of high affinity inhibitors of PIM-1 such as imidazo[1,2-b]pyridazines, pyrazolo[1,5-a]pyrimidines, and members of the flavonoid family. In this paper we present an initial SAR of the identified scaffolds determined on the basis of a thermostability shift assay, calorimetric binding data, and biochemical assays which may find applications for the treatment of PIM-1 dependent cancer types.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302800     DOI: 10.1021/jm0504858

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  45 in total

Review 1.  For better or for worse: the role of Pim oncogenes in tumorigenesis.

Authors:  Martijn C Nawijn; Andrej Alendar; Anton Berns
Journal:  Nat Rev Cancer       Date:  2010-12-09       Impact factor: 60.716

2.  Similar biological activities of two isostructural ruthenium and osmium complexes.

Authors:  Jasna Maksimoska; Douglas S Williams; G Ekin Atilla-Gokcumen; Keiran S M Smalley; Patrick J Carroll; Richard D Webster; Panagis Filippakopoulos; Stefan Knapp; Meenhard Herlyn; Eric Meggers
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

3.  Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.

Authors:  Mustapha Haddach; Jerome Michaux; Michael K Schwaebe; Fabrice Pierre; Sean E O'Brien; Cosmin Borsan; Joe Tran; Nicholas Raffaele; Suchitra Ravula; Denis Drygin; Adam Siddiqui-Jain; Levan Darjania; Ryan Stansfield; Chris Proffitt; Diwata Macalino; Nicole Streiner; Joshua Bliesath; May Omori; Jeffrey P Whitten; Kenna Anderes; William G Rice; David M Ryckman
Journal:  ACS Med Chem Lett       Date:  2011-12-27       Impact factor: 4.345

4.  Synthesis and Biological Evaluation of Pyrazolo[1,5-a]pyrimidine Compounds as Potent and Selective Pim-1 Inhibitors.

Authors:  Yong Xu; Benjamin G Brenning; Steven G Kultgen; Jason M Foulks; Adrianne Clifford; Shuping Lai; Ashley Chan; Shannon Merx; Michael V McCullar; Steven B Kanner; Koc-Kan Ho
Journal:  ACS Med Chem Lett       Date:  2014-10-22       Impact factor: 4.345

Review 5.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

6.  Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.

Authors:  Zuping Xia; Christian Knaak; Jian Ma; Zanna M Beharry; Campbell McInnes; Wenxue Wang; Andrew S Kraft; Charles D Smith
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

7.  Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion.

Authors:  Niina M Santio; Riitta L Vahakoski; Eeva-Marja Rainio; Jouko A Sandholm; Sanna S Virtanen; Michelle Prudhomme; Fabrice Anizon; Pascale Moreau; Päivi J Koskinen
Journal:  Mol Cancer       Date:  2010-10-19       Impact factor: 27.401

8.  Structural comparison of human mammalian ste20-like kinases.

Authors:  Christopher J Record; Apirat Chaikuad; Peter Rellos; Sanjan Das; Ashley C W Pike; Oleg Fedorov; Brian D Marsden; Stefan Knapp; Wen Hwa Lee
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

9.  Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.

Authors:  Alex N Bullock; Santina Russo; Ann Amos; Nicholas Pagano; Howard Bregman; Judit E Debreczeni; Wen Hwa Lee; Frank von Delft; Eric Meggers; Stefan Knapp
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

10.  Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration.

Authors:  Rebekka Grundler; Laurent Brault; Christelle Gasser; Alex N Bullock; Tobias Dechow; Sabine Woetzel; Vanda Pogacic; Antonello Villa; Sabine Ehret; Georgina Berridge; Anke Spoo; Christine Dierks; Andrea Biondi; Stefan Knapp; Justus Duyster; Juerg Schwaller
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.